Freenome

About Freenome

Freenome is a pioneering biotechnology company based in the UK, dedicated to revolutionising cancer detection and prevention through advanced artificial intelligence and multi-omics technology. Our mission is to empower individuals with early cancer detection tools that can significantly improve treatment outcomes and save lives.

At Freenome, we focus on developing non-invasive blood tests that leverage machine learning algorithms to analyse complex biological data. This innovative approach allows us to identify cancer at its earliest stages, even before symptoms arise. Our team of experts combines expertise in genomics, proteomics, and bioinformatics to create cutting-edge diagnostic solutions.

We believe that early detection is key to effective cancer treatment, and our vision is to make these life-saving tests accessible to everyone. By collaborating with healthcare providers and researchers, we aim to integrate our technologies into routine clinical practice, ensuring that patients receive timely and accurate diagnoses.

Our commitment to research and development drives us to continuously enhance our testing capabilities. We are actively engaged in clinical trials and partnerships with leading institutions to validate our technologies and expand our test offerings.

As a company, we value innovation, integrity, and collaboration. Our diverse team is united by a shared passion for improving patient outcomes and advancing the field of oncology. We are excited about the future of cancer care and are dedicated to making a meaningful impact in the lives of patients and their families.

Join us on our journey to transform cancer detection and prevention, and together, we can create a healthier future for all.